The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
The EMBO Journal, Aug 09, 2007
Proper regulation of cell cycle progression is pivotal for maintaining genome stability. In a search for DNA damage-inducible, CHK1-modulated genes, we have identified BTG3 (B-cell translocation gene 3) as a direct p53 target.